Saurabh B. Ganorkar

Dr. Saurabh B. Ganorkar


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2017 in Reviews in Analytical Chemistry
Verified
Journal Article
Open access
PDF file
SGSaurabh B. Ganorkar
Saurabh B. Ganorkar
ASAtul A. Shirkhedkar
Atul A. Shirkhedkar
This review presents the essential brief annals, crucial analytics, precise applications and noteworthy implications of design of experiments which enrouted to liquid chromatography (LC) in the midst of utmost focus on high-performance liquid-chromatography (HPLC) and broadened its impressions on allied techniques in pharmaceutical analysis. Being most widely applied statistical methodologies for such purpose, its use was started in 1970 and heightened after Fischer’s precious input in 1981. The persistent use of statistical approaches one after another led to the efficient attention of pharmaceutical analysts. Hence, in order to fine-tune the trail impressed by the cumulative trends, the use of statistical designs in HPLC analysis has been reviewed and efforts were made to recognize its relative impact and corresponding future prospects. Applications of precise methodologies have been reassessed with respect to the need established by recent regulatory perspectives with a fanatical and the consequent stance on prominent historical advancements and concrete purposes. An effort was also made to state an arbitrary classification of diverse design types and succinct line of application in LC and associated analyses.

10 August 2020 in Critical Reviews in Analytical Chemistry
Verified
Journal Article
Closed access
MPMangesh R. Patil
Mangesh R. Patil
SGSaurabh B. Ganorkar
Saurabh B. Ganorkar
APAmod S. Patil
Amod S. Patil
ASAtul A. Shirkhedkar
Atul A. Shirkhedkar
Terahertz (THz) spectroscopy is an emerging field for quality control of pharmaceuticals, which uses T-waves for detection. T-waves fall in between infrared and microwave radiations while possessing some of the characteristics of both. THz spectroscopy reveals its existence in between 0.1 and 10 THz. These radiations have the ability to penetrate a broad range of non-conductive materials and it is nonionizing. The first article stating the use of THz radiations was found in late 1960 for the generation of the astronomical images. This review essentially creates attention toward different forms and instrumentation of THz spectroscopy along with the updates for timely and upbeat pharmaceutical applications. The most frequently used technique is THz-TDS which has profoundly privileged applicability for the pharmaceuticals. The existing literature of THz spectroscopy further created albeit interest to explore the applications for future implementation in concern with the pharmaceuticals. The review critically outlines here all the pharmaceutical applications of THz spectroscopy including protein analyses, crystallinity studies, evaluating tablet films and coats, medicinal aging variations, and detection of illicit drugs, along with the advantages over traditional techniques. The other side of THz spectroscopy stating limitations is also studied and taken into the note to present here. This review is a genuine attempt to quote and crucially assess the possible as well as anticipated prospectives for the pharmaceuticals. The present article will further promote the awareness, opportunities, and scientific exploration of this exciting technology as THz spectroscopy.

26 January 2025 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SGSaurabh B. Ganorkar
Saurabh B. Ganorkar
PHPranay M. Hadole
Pranay M. Hadole
MPMangesh R. Patil
Mangesh R. Patil
CPChandrakantsing V. Pardeshi
Chandrakantsing V. Pardeshi
PBPreeti S. Bobade
Preeti S. Bobade
YHYvan Vander Heyden
Yvan Vander Heyden

31 July 2022 in TrAC Trends in Analytical Chemistry
Verified
Journal Article
Closed access
SGSaurabh B. Ganorkar
Saurabh B. Ganorkar
YHYvan Vander Heyden
Yvan Vander Heyden

31 January 2020 in Critical Reviews in Analytical Chemistry
Verified
Journal Article
Closed access
MPMangesh R. Patil
Mangesh R. Patil
SGSaurabh B. Ganorkar
Saurabh B. Ganorkar
APAmod S. Patil
Amod S. Patil
ASAtul A. Shirkhedkar
Atul A. Shirkhedkar
SSSanjay. J. Surana
Sanjay. J. Surana
The hydrotropy though existing as precisely used scientific approach assisting solubilization for all. It took 66 long years to use the concept in drug analysis since its inception in 1916 and first use for facilitation of drug solubility toward better pharmaceutical analysis in 1982. Considering the unending importance in pharmaceutical sciences and thereby in analysis, it’s a necessity to comprehensively outlook the origin, evolution, cumulative trend and precise applications in pharmaceutical analysis. Achieved hereby with chronological and comparative assessment of the studies published pertaining to solubility enhancement of poorly soluble drugs with use of hydrotropic agents alone or in combination for assisting pharmaceutical analysis. The thorough literature searches resulted into 77 references over a span of about 38 years. This comprehensive review critically evaluates existing literature; to our surprise we found Ibuprofen sodium, Lignocaine, Niacinamide and Metformin HCl as atypical hydrotropic agents. We also compared herein mono and mixed approaches which indicated prevalence of mono - hydrotropy over mixed. The possible mechanisms behind solubilization are presented for an additional insight. An essential effort has been made to state arbitrary classification to assist in future applications. The obvious purpose of this study was to collectively evaluate the crucial role of hydrotropic agents in pharmaceutical analyses for better drug delivery. This comprehensive review covers all details since inception to the updates till date which will definitely act as appropriate guideline for pharmaceutical analyst’s in need of hydrotropy to assist pharmaceutical analysis for therapies today and tomorrow.

1 February 2020 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Open access
SGSaurabh B. Ganorkar
Saurabh B. Ganorkar
YHYvan Vander Heyden
Yvan Vander Heyden
ASAtul A. Shirkhedkar
Atul A. Shirkhedkar
DLDeepak Lokwani
Deepak Lokwani
DDDinesh M. Dhumal
Dinesh M. Dhumal
PBPreeti S. Bobade
Preeti S. Bobade
The obligatory testing of drug molecules and their impurities to protect users against toxic compounds seems to provide interesting opportunities for new drug discovery. Impurities, which proved to be non-toxic, may be explored for their own therapeutic potential and thus be a part of future drug discovery. The essential role of pharmaceutical analysis can thus be extended to achieve this purpose. The present study examined these objectives by characterizing the major degradation products of zileuton (ZLT), a 5-lipoxygenase (5-LOX) inhibitor being prevalently used to treat asthma. The drug sample was exposed to forced degradation and found susceptible to hydrolysis and oxidative stress. The obtained Forced Degradation Products (FDP's) were resolved using an earlier developed and validated Ultra-High-Pressure Liquid Chromatography Photo-Diode-Array (UHPLC-PDA) protocol. ZLT, along with acid-and alkali-stressed samples, were subjected to Liquid-chromatography Mass-spectrometry Quadrupole Time-of-flight (LC/MS-QTOF) studies. Major degradation products were isolated using Preparative TLC and characterized using Q-TOF and/or Proton nuclear magnetic resonance (1HNMR) studies. The information obtained was assembled for structural conformation. Toxicity Prediction using Komputer Assisted Technology (TOPKAT) toxicity analyses indicated some FDP's as non-toxic when compared to ZLT. Hence, these non-toxic impurities may have bio-affinity and can be explored to interact with other therapeutic targets, to assist in drug discovery. The drug molecule and the characterized FDP's were subjected to 3-Dimensional Extra Precision (3D-XP)-molecular docking to explore changes in bio-affinity for the 5-LOX enzyme (PDB Id: 3V99). One FDP was found to have a higher binding affinity than the drug itself, indicating it may be a suitable antiasthmatic. The possibility of being active at other sites cannot be neglected and this is evaluated to a reasonable extent by Prediction of Activity Spectra for Substances (PASS). Besides being antiasthmatic, some FDP's were predicted antineoplastic, antiallergic and inhibitors of Complement Factor-D.